These medtech companies raised the most VC last year


4 (tied). NeuroPace

Mountain View, Calif.
Venture capital raised: $50 million


Neuropace raised $50 million in venture capital in the first quarter of 2017, according to the MoneyTree Report. This is the company’s fourth investment sequence. Investors include Johnson & Johnson Innovation, KCK Group and Kleiner Perkins Caufield & Byers.

NeuroPace develops implantable devices that treat neurological disorders using neurostimulation. The company developed the RNS System originally to treat epilepsy. It is the first and only medical device that can monitor and respond to brain activity, according to the company.

Next >>

Join the Best Minds in MedTech at DeviceTalks Minnesota!

textadimage This year’s DeviceTalks Minnesota features four tracks packed with expertly curated content created by the industry for the industry.

ECO-SYSTEM TRACK: focuses on issues impacting medtech companies across Minnesota and beyond. TECHNOLOGY TRACK: drills down on the hottest new tech that is changing medtech. REGULATORY 201 and CLINCAL 201 TRACKS: Hosted by Medical Alley and focuses on the most important trends in regulatory and clinical development.

Take a look at our full agenda.

Use the code "TRACKS" to save 15% on the cost of registration. 


Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Speak Your Mind